Fort L.P. Reduces Position in Chemed Co. (NYSE:CHE)

Fort L.P. lessened its holdings in shares of Chemed Co. (NYSE:CHE) by 4.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 400 shares of the company’s stock after selling 20 shares during the quarter. Fort L.P.’s holdings in Chemed were worth $240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. GAMMA Investing LLC raised its position in shares of Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust bought a new stake in shares of Chemed during the 3rd quarter valued at $61,000. EntryPoint Capital LLC raised its position in shares of Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares during the period. Mather Group LLC. raised its position in shares of Chemed by 60.5% during the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the period. Finally, Quarry LP raised its position in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other Chemed news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the sale, the director now directly owns 5,725 shares in the company, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Chemed news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,144 shares of company stock worth $4,141,679. Insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of CHE stock traded down $8.56 on Friday, hitting $531.68. 225,338 shares of the stock traded hands, compared to its average volume of 85,325. The firm has a market cap of $8.00 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 2.18 and a beta of 0.44. Chemed Co. has a 52 week low of $525.36 and a 52 week high of $654.62. The firm has a 50 day simple moving average of $585.30 and a two-hundred day simple moving average of $567.98.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.32 earnings per share. Sell-side analysts forecast that Chemed Co. will post 21.77 EPS for the current year.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.